Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure

NCT04318093 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Decompensated Heart Failure

Interventions

DRUG: BMS-986259
OTHER: Placebo

Sponsor

Bristol-Myers Squibb